flu shot and glp 1 Could GLP-1 medications help slow cancer progression? A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Annual Flu Shots Clinic Near
Description
Thank you Jeffrey Perl Bargman Joanne and Wendy (Wen Qing) Ye Experienced and innovative Medical leader - focused on patient centricity and evidence based communication

Tirzepatide vs Ozempic key differences Tirzepatide and Ozempic both activate the GLP-1 pathway, while only Tirzepatide activates the GIP pathway
Patients should understand that expected weight loss varies by medication (approximately 5-10% with liraglutide, 10-15% with semaglutide, and potentially higher with tirzepatide), though responses in post-bariatric patients may differ from those in primary obesity treatment
This means long-term risks matter more than ever

But if a patient taking these drugs experiences vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication

Lets get started
